8-K
Current Report
Oric Pharmaceuticals, Inc. Filed Acc 0000950170-25-107313
Results of operations · Exit or restructuring costs
- Item 2.02 Results of operations and financial condition
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading oric-20250812.htm…